Baytril Taste Tabs 136mg (per tablet)

View other items in the same category as Baytril Taste Tabs 136mg (per tablet)

Price $3.25

Product Uses

Baytril Taste Tabs are indicated for the management of diseases in cats and dogs associated with bacteria susceptible to enrofloxacin.

In dogs, clinical efficacy has been established in dermal infections (wounds and abscesses), respiratory infections and urinary cystitis associated with susceptible strains of bacteria.

In cats, clinical efficacy has been established in dermal infections (wounds and abscesses) associated with susceptible strains of bacteria.

Product Contains

enrofloxacin

Dosage and Administration

Dogs: Administer orally at a rate of 5-20 mg/kg (2.27 to 9.07 mg/lb) of body weight. Animals which receive doses in the upper-end of the dose range should be carefully monitored for clinical signs that may include loss of appetite, depression, and vomiting.

Cats: Administer orally at 5 mg/kg (2.27 mg/lb) of body weight.

The dose for dogs and cats may be administered either as a single daily dose or divided into two equal daily doses administered at twelve hour intervals. The dose should be continued for at least 2-3 days beyond resolution of clinical signs, up to a maximum of 30 days. If no improvement is seen within five days, the diagnosis should be reevaluated and a different course of therapy considered.

All tablet sizes are double scored for accurate dosing.

Baytril Taste Tabs are palatable and most dogs will consume them willingly when offered by hand, but they may be offered in food or hand-administered (pilled) as with other oral tablet medications. In cats, Baytril Taste Tabs Tablets should be pilled. After administration, it is advised that owners watch the animal closely to be certain the entire dose has been consumed.

Warnings, Side Effects and Drug Interactions

Enrofloxacin is contraindicated in dogs known to be hypersensitive to quinolones.

The use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age). The safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase. Large breeds may be in this phase for up to one year of age and the giant breeds for up to 18 months.

Concomitant therapy with other drugs that are metabolized in the liver may reduce the clearance rates of enrofloxacin and the other drug.

Enrofloxacin has been administered to dogs at a daily dosage rate of 10 mg/kg concurrently with a wide variety of other health products including anthelmintics (praziquantel, febantel), insecticides (pyrethrins), heartworm preventatives (diethylcarbamazine) and other antibiotics (ampicillin, gentamicin sulfate, penicillin). No incompatibilities with other drugs are known at this time.

Humans with a history of hypersensitivity to quinolones should avoid handling this product. In humans, there is a risk of user photosensitization within a few hours after excessive exposure to quinolones. If excessive accidental exposure does occur, avoid direct sunlight.

Quinolone-class drugs should be used with caution in animals with known or suspected nervous system disorders. Rarely, these medications have been associated with seizures, as well as behavioral changes such as depression, lethargy and nervousness in cats and dogs.

The use of this product in cats may result in retinal toxicity.

Extreme overdosing of Baytril has been associated with vomiting, inappetence, depression, difficult locomotion and death. Should these, or any other signs of toxicity be seen with this product, discontinue use and contact your veterinarian immediately.

Storage

Store tablets in tight containers only.

Manufacturer

Bayer HealthCare LLC, Animal Health Division

Registration Status

NADA # 140-441, Approved by the FDA

Federal law restricts this drug to use by or on the order of a licensed veterinarian. Federal law prohibits the extralabel use of this drug in food-producing animals.